Back to User profile » Dr Fabrizio Cantini

Papers published by Dr Fabrizio Cantini:

Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data

Benucci M, Damiani A, Li Gobbi F, Grossi V, Infantino M, Manfredi M, Niccoli L, Cantini F

Therapeutics and Clinical Risk Management 2020, 16:287-297

Published Date: 16 April 2020

Therapeutic strategies utilization and resource consumption in patients treated for psoriatic arthritis: findings from a real-world analysis in an Italian setting

Degli Esposti L, Perrone V, Sangiorgi D, Alessandrini D, Buda S, Cantini F, Mazzini E, Toma C, De Solda F

Patient Preference and Adherence 2019, 13:187-194

Published Date: 22 January 2019

Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables

Niccoli L, Nannini C, Blandizzi C, Mantarro S, Mosca M, Di Munno O, Goletti D, Benucci M, Li Gobbi F, Cassarà E, Kaloudi O, Cantini F

Therapeutics and Clinical Risk Management 2018, 14:2097-2111

Published Date: 24 October 2018

Focus on biosimilar etanercept – bioequivalence and interchangeability

Cantini F, Benucci M

Biologics: Targets and Therapy 2018, 12:87-95

Published Date: 30 August 2018

Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

Cantini F, Niccoli L, Nannini C, Kaloudi O, Cassarà E, Susini M, Lenzetti I

Biologics: Targets and Therapy 2012, 6:5-12

Published Date: 29 December 2011